References
- Alfrey AC. 1993. Aluminum toxicity in patients with chronic renal failure. Ther Drug Monit 15:593–597.
- Anane R, Bonini M, Grafeille JM, Creppy EE. 1995. Bioaccumulation of water soluble aluminium chloride in the hippocampus after transdermal uptake in mice. Arch Toxicol 69:568–571.
- Burkhart CG, Burkhart CN. 2008. Aluminum alters sweating by constricting the dermal duct lumen. Int J Dermatol 47:1306–1307.
- Darbre PD. 2005. Aluminium, antiperspirants and breast cancer. J Inorg Biochem 99:1912–1919.
- De Wolff FA, Van der Voet GB. Intestinal absorption of aluminium. In: De Broe ME; Coburn JW, editors. Aluminium and Renal Failure. Kluwer Academic Publishers; Dordrecht, The Netherlands: 1990. p. 41–56.
- Exley C, Burgess E, Day JP, Jeffery EH, Melethil S, Yokel RA. 1996. Aluminum toxicokinetics. J Toxicol Environ Health 48:569–584.
- Exley C. 1998. Does antiperspirant use increase the risk of aluminium-related disease, including Alzheimer’s disease? Mol Med Today 4:107–109.
- Exley C. 2004. Aluminum in antiperspirants: more than just skin deep. Am J Med 117:969–970.
- Flarend R, Bin T, Elmore D, Hem SL. 2001. A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem Toxicol 39:163–168.
- Franz TJ. 1975. Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 64:190–195.
- Guillard O, Fauconneau B, Olichon D, Dedieu G. 2004. Hyperaluminemia in a woman using an aluminium-containing antiperspirant for 4 years. Am J Med 117:956–959.
- Guillard O, Tiphaneau K, Reiss D, Piriou A. 1984. Improved determination of aluminium in serum by electrothermal atomic absorption spectrometry and Zeeman background correction. Anal Lett 17:1593–1605.
- Guillard O, Pineau A, Baruthio F, Arnaud J. 1988. An international quality-assessment program for measurement of aluminum in human plasma: a progress report. Clin Chem 34:1603–1604.
- Pineau A, Guillard O, Chappuis P, Arnaud J, Zawislak R. 1993. Sampling conditions for biological fluids for trace element monitoring in hospital patients: a critical approach. Crit Rev Clin Lab Sci 30:203–222.
- Quatrale RP. The mechanism of antiperspirant action in eccrine sweat glands. In: Ladan K; Felger CB, editors. Antiperspirants and Deodorants. Marcel Dekker; New York: 1988. p. 87–95.
- Savory J, Exley C, Forbes WF, Huang Y, Joshi JG, Kruck T, McLachlan DR, Wakayama I. 1996. Can the controversy of the role of aluminum in Alzheimer’s disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered? J Toxicol Environ Health 48:615–635.
- Teagarden DL, Hem SL, White JL. 1982. Conversion of aluminium chlorohydrate to aluminium hydroxide. J Soc Cosmet Chem 33:281–295.
- van Ginkel MF, van der Voet GB, de Wolff FA. 1990. Improved method of analysis for aluminum in brain tissue. Clin Chem 36:658–661.
- Weber JP. 1988. An interlaboratory comparison program for several toxic substance in blood and urine. Sci Total Environ 71:111–123.
- Weberg R, Berstad A. 1986. Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. Eur J Clin Invest 16:428–432.
- Wulf RJ. Safety of Antiperspirant Salts. In: Laden K., editor. Antiperspirants and Deodorants. Marcel Dekker; New York: 1999. p. 215–232.